A case report of familial 4q13.3 microdeletion in three individuals with syndromic intellectual disability.


Journal

BMC medical genomics
ISSN: 1755-8794
Titre abrégé: BMC Med Genomics
Pays: England
ID NLM: 101319628

Informations de publication

Date de publication:
16 04 2020
Historique:
received: 06 06 2019
accepted: 08 04 2020
entrez: 18 4 2020
pubmed: 18 4 2020
medline: 11 5 2021
Statut: epublish

Résumé

Interstitial 4q deletions are rare chromosomal alterations. Most of the previously reported deletions involving the 4q13.3 region are large chromosomal alterations with a common loss of band 4q21 resulting in marked growth restriction, severe intellectual disability, and absent or severely delayed speech. A microdeletion of 4q13.3 hasn't been previously reported. We discuss the involvement of genes and the observed phenotype, comparing it with that of previously reported patients. We report on a 4q13.3 microdeletion detected in three affected individuals of a Lithuanian family. The clinical features of two affected children and their affected mother are very similar and include short stature, congenital heart defect, skeletal anomalies, minor facial anomalies, delayed puberty, and intellectual disability. Whole genome SNP microarray analysis of one child revealed an interstitial 4q13.3 microdeletion, 1.56 Mb in size. FISH analysis confirmed the deletion in the proband and identified the same deletion in her affected sib and mother, while it was not detected in a healthy sib. Deletion includes ADAMTS3, ANKRD17, COX18, GC, and NPFFR2 protein-coding genes. Our findings suggest that 4q13.3 microdeletion is a cause of a recognizable phenotype of three affected individuals. The detected microdeletion is the smallest interstitial deletion in 4q13. We highlight ADAMTS3, ANKRD17 and RNU4ATAC9P as candidate genes for intellectual disability, growth retardation and congenital heart defect.

Sections du résumé

BACKGROUND
Interstitial 4q deletions are rare chromosomal alterations. Most of the previously reported deletions involving the 4q13.3 region are large chromosomal alterations with a common loss of band 4q21 resulting in marked growth restriction, severe intellectual disability, and absent or severely delayed speech. A microdeletion of 4q13.3 hasn't been previously reported. We discuss the involvement of genes and the observed phenotype, comparing it with that of previously reported patients.
CASE PRESENTATION
We report on a 4q13.3 microdeletion detected in three affected individuals of a Lithuanian family. The clinical features of two affected children and their affected mother are very similar and include short stature, congenital heart defect, skeletal anomalies, minor facial anomalies, delayed puberty, and intellectual disability. Whole genome SNP microarray analysis of one child revealed an interstitial 4q13.3 microdeletion, 1.56 Mb in size. FISH analysis confirmed the deletion in the proband and identified the same deletion in her affected sib and mother, while it was not detected in a healthy sib. Deletion includes ADAMTS3, ANKRD17, COX18, GC, and NPFFR2 protein-coding genes.
CONCLUSIONS
Our findings suggest that 4q13.3 microdeletion is a cause of a recognizable phenotype of three affected individuals. The detected microdeletion is the smallest interstitial deletion in 4q13. We highlight ADAMTS3, ANKRD17 and RNU4ATAC9P as candidate genes for intellectual disability, growth retardation and congenital heart defect.

Identifiants

pubmed: 32299451
doi: 10.1186/s12920-020-0711-4
pii: 10.1186/s12920-020-0711-4
pmc: PMC7160938
doi:

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

63

Références

J Appl Genet. 2014 May;55(2):189-96
pubmed: 24535828
Am J Med Genet A. 2015 Jan;167A(1):231-7
pubmed: 25355368
J Med Genet. 2010 May;47(5):289-97
pubmed: 19951919
Am J Med Genet C Semin Med Genet. 2008 Nov 15;148C(4):257-69
pubmed: 18932124
Nat Commun. 2015 Nov 02;6:8718
pubmed: 26522830
Am J Med Genet A. 2015 Dec;167A(12):3113-20
pubmed: 26284580
Cytogenet Genome Res. 2018;154(1):6-11
pubmed: 29421787
Genet Couns. 2011;22(4):353-63
pubmed: 22303795
Am J Med Genet A. 2013 Aug;161A(8):2078-83
pubmed: 23825006
J Med Genet. 2010 Jun;47(6):377-84
pubmed: 20522426
Development. 2006 Apr;133(8):1587-96
pubmed: 16556917
J Cell Mol Med. 2017 Jan;21(1):185-192
pubmed: 27561207
FEBS Lett. 2009 Sep 3;583(17):2765-71
pubmed: 19619540
Am J Med Genet. 1997 Apr 14;69(4):400-5
pubmed: 9098490
Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
J Biol Chem. 2009 Mar 20;284(12):7875-88
pubmed: 19150984
J Biol Chem. 2009 Nov 13;284(46):31493-7
pubmed: 19734141

Auteurs

Živilė Maldžienė (Ž)

Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Santariškių st. 2, 08661, Vilnius, LT, Lithuania. zivile.maldziene@mf.vu.lt.

Evelina M Vaitėnienė (EM)

Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Beata Aleksiūnienė (B)

Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Santariškių st. 2, 08661, Vilnius, LT, Lithuania.

Algirdas Utkus (A)

Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Santariškių st. 2, 08661, Vilnius, LT, Lithuania.

Eglė Preikšaitienė (E)

Department of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Santariškių st. 2, 08661, Vilnius, LT, Lithuania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH